CD8A and neoplasm: Consistent with the above results, in the distant tumor, the number of CD8+ T cells, especially Ki67+CD8+ T cells, exhibited an obvious increase in the second tumor (Fig. 4f, i), and the percentages of Tregs were decreased in FCS/aPDL1/aCTLA4 treated group (Fig. 4j).